India Firm to market AIDS drugs in Tanzania

Dar es Salaam- Tanzania (PANA) -- An Indian company, CIPL's Pharmaceuticals, plans to market in Tanzania, cheaper HIV/AIDS anti-retroviral drugs as the government grapples with the epidemic, the local press reported Tuesday.
The "African" newspaper reported that this was part of issues discussed by a Tanzanian delegation led by Foreign Affairs and International Co-operation Minister, Jakaya Kikwete, which visited India recently for the Indo-Tanzania Joint Commission meeting The Minister was said to have visited CIPL's plant and held discussions on areas of co-operation between the two countries in the fight against the AIDS pandemic.
"The pharmaceutical company may soon send a delegation to Tanzania to finalise some technical aspects," the paper quoted the Indian High Commissioner to Tanzania, Virendra Gupta, as saying.
Anti-retroviral drugs manufactured in India cost a 10th of the price charged for similar drugs manufactured by Western pharmaceutical companies.
Gupta said the India option would offer an affordable recourse to the poor, who constituted the majority of AIDS sufferers.
One out of every 10 Tanzanians is suspected of carrying the HIV virus that causes AIDS, in the country of some 31 million people.

05 june 2001 10:34:00

xhtml CSS